The excellent news: a monoclonal antibody treatment called benralizumab proved quite effective in a clinical trial at depleting the variety of eosinophils present in the blood and digestive tract tissues of patients with eosinophilic gastritis. The not-so-good news: eliminating eosinophils was not enough to stop the symptoms people feel with this unusual and severe type […]